PROMETHAZINE HYDROCHLORIDE
- Product NDC
- 68071-4737
- Requested package NDC
- 68071-4737-6
- 11-digit product format
- 680714737
- Labeler code
- 68071
- Product ID
- 68071-4737_50289e7b-d122-11a1-e063-6394a90ac840
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- promethazine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA040712
- Marketing category
- ANDA
- Marketing start
- 2006-07-31
- Substance
- PROMETHAZINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Phenothiazine [EPC], Phenothiazines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040712-001 | PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2006-07-31 | |
| A040712-002 | PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | 12.5MG | TABLET / ORAL | AB | 2007-05-04 | |
| A040712-003 | PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 2006-07-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040712-001 | AB |
| A040712-002 | AB |
| A040712-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040712-001 | PROMETHAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2006-07-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040712-002 | PROMETHAZINE HYDROCHLORIDE | 12.5MG | TABLET / ORAL | AB | 2007-05-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040712-003 | PROMETHAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 2006-07-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040712-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040712-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040712-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 6bcaa89f-5f14-dc45-e053-2a91aa0aac54 | 2026-07-30 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 804e2525-d61f-7bed-e053-2991aa0a5daa | 2026-06-30 | Warnings, Adverse reactions | 040712 ANDA040712 68071-4737-6 68071-4737 68071473706 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Bryant Ranch Prepack | e6d940f8-fa1a-4a75-b4fc-2cbbaf7a0488 | 2026-06-05 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Bryant Ranch Prepack | f9ff2bd5-6464-4c9e-b2ed-dcd2dbe83c47 | 2026-06-04 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 5ce082e9-13eb-4e63-a9e2-657d3ef0e9f8 | 2026-05-22 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f93ca67d-362a-473f-8296-2952da77c074 | 2026-05-22 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | b0ba50da-9f70-4531-a9de-3dd3f8aa1f5d | 2026-05-22 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | KVK-Tech, Inc. | 7a137adf-39b7-4b14-80da-c3cac9ad562a | 2026-03-13 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Northwind Health Company, LLC | d9cb1a44-d646-d9e9-e053-2995a90a24ff | 2026-01-01 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 7e5715cf-056f-4095-e053-2991aa0ad3e5 | 2024-06-12 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | A-S Medication Solutions | a7b1e8b2-6f20-4096-87c7-cf349ed4f7b9 | 2023-12-15 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | A-S Medication Solutions | b54439a3-1d01-4c5f-8508-731790ae215b | 2023-12-15 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | A-S Medication Solutions | b96904e7-cc67-4abc-b946-8423f3f897ff | 2023-10-24 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | A-S Medication Solutions | 2c9a4767-23c4-4a1c-bb4c-2bad1351c270 | 2023-05-08 | Warnings, Adverse reactions | 040712 ANDA040712 |
| Promethazine | PROMETHAZINE | PharmPak, Inc. | 4f681538-7ac4-484c-9e6d-b571d73b9e0b | 2022-10-08 | Warnings, Adverse reactions | 040712 ANDA040712 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Proficient Rx LP | 29a8b172-1bad-40db-8d73-1fe7fb309cff | 2022-04-01 | Warnings, Adverse reactions | 040712 ANDA040712 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PROMETHAZINE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PROMETHAZINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R61ZEH7I1I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 992447 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 804e2525-d61f-7bed-e053-2991aa0a5daa | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3036445d-7d13-4411-a100-f2ac5ab8a276 | Product name | 1 | 20240110 |
| 2e7222fb-e3f1-febd-962f-ddbb495d6b5f | Product name | 2 | 20220126 |
| 09d8330d-4fec-be98-3a66-f985140646b2 | Product name | 2 | 20210513 |
| 4f881de7-085a-407e-abc2-faa3c0127432 | Product name | 1 | 20170811 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
| d51697af-7f97-0559-95d1-fe94f3f031d5 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4737-6 | 2024-06-12 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2024-06-12 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2021-02-17 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2021-02-17 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 68071-4737-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2ed7-a910-e053-dadaa90a0b85 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4737-3 | PROMETHAZINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 68071-4737-6 | PROMETHAZINE HYDROCHLORIDE | 6 in 1 BOTTLE | TABLET | 6 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4737 | PROMETHAZINE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240614_804e2525-d61f-7bed-e053-2991aa0a5daa.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 992447 | promethazine HCl 25 MG Oral Tablet | PSN | 804e2525-d61f-7bed-e053-2991aa0a5daa | 4 |
| 992447 | promethazine hydrochloride 25 MG Oral Tablet | SCD | 804e2525-d61f-7bed-e053-2991aa0a5daa | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-4737-6 | 68071473706 | 6 TABLET in 1 BOTTLE (68071-4737-6) | 6 tablet | 2019-01-25 | 0000-00-00 | No | No | Current |